• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 24, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Boston College biologist Emrah Altindis awarded grant from the Mathers Foundation

Bioengineer by Bioengineer
February 5, 2020
in Biology
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Mathers Foundation funding will support research into Type 1 diabetes

IMAGE

Credit: Peter Julian/Boston College

Boston College Assistant Professor of Biology Emrah Altindis has received a three-year, $300,000-grant from the G. Harold and Leila Y. Mathers Foundation for research into Type 1 diabetes.

Altindis and his team will explore the roles gut microbes and viruses play in triggering the autoimmunity of Type 1 diabetes.

According to Altindis, molecular mimicry is one autoimmune mechanism in which the immune system cannot distinguish between a foreign antigen that shares a structural similarity with a host protein and the actual host protein.

Altindis recently discovered viral insulins and bacterial insulin epitope mimics. Altindis’ lab is looking for evidence that Type 1 diabetes is caused by a molecular mimicry mechanism, where exposure to a microbial insulin or insulin epitope mimic elicits an autoimmune response, which attacks both the microbial insulin and our own normal insulin and causes Type 1 diabetes.

“The main focus of our lab’s research is to understand the role of microbial mimics of human hormones in human disease and health,” said Altindis. “We are very grateful to receive this award and recognition of our work in this early stage by the Mathers Foundation. This awarded project is at the center of our research program. It will allow me to ask some high risk/high reward questions that have the potential to better understand the cause of Type 1 diabetes.”

The Mathers Foundation sponsors scientific research to advance knowledge in the life sciences, with potential translational applications.

###

Media Contact
Ed Hayward
[email protected]
617-552-4826

Tags: BiologyMolecular Biology
Share19Tweet12Share3ShareShareShare2

Related Posts

Cochrane Map Reveals Major Evidence Gaps in Dengue Prevention Research

Cochrane Map Reveals Major Evidence Gaps in Dengue Prevention Research

August 24, 2026
Delayed antiviral response in alveolar type 2 cells heightens influenza susceptibility

Delayed antiviral response in alveolar type 2 cells heightens influenza susceptibility

August 22, 2026

Genetic evidence links sleep disruption to hemorrhoidal disease, revealing a hidden connection

August 22, 2026

LASIK Versus Contact Lenses for Correcting Myopia

August 22, 2026
Please login to join discussion

POPULAR NEWS

  • Cochrane Map Reveals Major Evidence Gaps in Dengue Prevention Research

    Cochrane Map Reveals Major Evidence Gaps in Dengue Prevention Research

    29 shares
    Share 12 Tweet 7
  • Study reveals surge in type 2 diabetes among people under 20

    29 shares
    Share 12 Tweet 7
  • KAIST discovers pathway to faster-charging, longer-lasting electric vehicle batteries

    29 shares
    Share 12 Tweet 7
  • Blocking glucosylceramide production kills cancer cells via lysosomal dysfunction, not ceramide buildup

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cochrane Map Reveals Major Evidence Gaps in Dengue Prevention Research

Study reveals surge in type 2 diabetes among people under 20

KAIST discovers pathway to faster-charging, longer-lasting electric vehicle batteries

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.